BioNTech CEO, Ugur Sahin…told the paper [WSJ] that, despite progress from various vaccine programs, it could take a decade to beat Covid-19.
Hence, COVID-19 therapeutics launched a few years from now may still find a market if they are better, or safer, than existing options (#msg-156749055).